McKesson stock hit a 52-week high of $215 this week, prompting CEO John Hammergren to sell 77,000 of his personal shares for a profit of $16 million.
DrFirst reports that 80 percent of New York providers and 85 percent of New York hospitals are prepared for the states I-STOP deadline, at which point all prescriptions, including controlled substances, must be sent electronically. While 97 percent of the states pharmacies are setup to receive electronic prescriptions, only 58 percent are equipped with the additional security features required to receive controlled substance prescriptions electronically.
BD Medical receives FDA clearance for a medication management system that focuses exclusively on IV bolus injections. The system verifies that the correct type and dose of medication are being administered, and checks for allergy conflicts at the point of administration, then it wirelessly records the medication administration in the EMR.